Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been given an average recommendation of “Moderate Buy” by the thirteen analysts that are covering the company, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $61.08.

TEM has been the topic of a number of research reports. Loop Capital dropped their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. JPMorgan Chase & Co. downgraded Tempus AI from an “overweight” rating to a “neutral” rating and upped their target price for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Wolfe Research downgraded shares of Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. William Blair restated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, TD Cowen reiterated a “buy” rating and issued a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th.

Insiders Place Their Bets

In other news, CAO Ryan M. Bartolucci sold 1,858 shares of the company’s stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $67.57, for a total transaction of $125,545.06. Following the completion of the transaction, the chief accounting officer now directly owns 55,379 shares of the company’s stock, valued at $3,741,959.03. This represents a 3.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of Tempus AI stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the sale, the director now directly owns 26,514 shares in the company, valued at approximately $1,207,447.56. This represents a 10.16 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,408,938 shares of company stock worth $262,986,880. Company insiders own 27.60% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. grew its holdings in shares of Tempus AI by 45.3% in the 1st quarter. Victory Capital Management Inc. now owns 9,305 shares of the company’s stock valued at $449,000 after acquiring an additional 2,901 shares in the last quarter. Bridgewater Advisors Inc. bought a new position in Tempus AI in the first quarter valued at approximately $259,000. Larson Financial Group LLC acquired a new position in shares of Tempus AI during the 1st quarter worth approximately $53,000. Massachusetts Financial Services Co. MA raised its stake in shares of Tempus AI by 92.6% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock worth $27,926,000 after purchasing an additional 278,311 shares in the last quarter. Finally, SBI Securities Co. Ltd. boosted its holdings in shares of Tempus AI by 10.9% in the 1st quarter. SBI Securities Co. Ltd. now owns 22,113 shares of the company’s stock valued at $1,067,000 after buying an additional 2,175 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Stock Performance

Shares of TEM stock opened at $57.06 on Monday. Tempus AI has a 52 week low of $22.89 and a 52 week high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company’s fifty day simple moving average is $48.11 and its 200-day simple moving average is $50.66.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.